Genetics in melanoma

Shy Stahl, Eran Bar-Meir, Eitan Friedman, Eli Regev, Arie Orenstein, Eyal Winkler

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Melanoma is the leading cause of death from skin tumors worldwide, with an annual increase in incidence over the past decade. The molecular mechanisms involved in melanoma pathogenesis are beginning to be unraveled. While a family history of melanoma and exposure to ultraviolet irradiation have been known for years as risk factors in melanoma development, the precise genes involved in inherited predisposition were defined only in the past decade. Germline mutations in two genes that play a pivotal role in controlling cell cycle and division - CDKN2A and cyclin-dependent kinase 4 (CDK4) - have been detected in autosomal, dominant, high penetrance familial melanoma cases. In addition to these two highly penetrant genes, germline mutations and polymorphisms in a few low penetrance genes have been reported in familial melanoma cases: melanocortin-1 receptor, epidermal growth factor, glutathione s-transferase M1, cytochrome p450 debrisoquine hydroxylase locus (CYP2D6) and vitamin D receptor.

Original languageEnglish
Pages (from-to)774-777
Number of pages4
JournalIsrael Medical Association Journal
Issue number12
StatePublished - Dec 2004
Externally publishedYes


  • CDK4
  • CDKN2A
  • Genetics
  • Inherited predisposition
  • Malignant melanoma


Dive into the research topics of 'Genetics in melanoma'. Together they form a unique fingerprint.

Cite this